Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
HPRA MIMS Articles October 2018
Notice type:
3rd Party Publications
Date:
13/12/2019
Ocaliva (obeticholic acid): Risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment – reminder of differential dosing recommendations
HPRA MIMS main book article October 2018 - Ocaliva
Valproate (Epilim): New contraindications, strengthened warnings and measures to prevent exposure during pregnancy
HPRA MIMS Women's Health supp. October 2018 - Valproate
Clarithromycin: Reminder on cardiovascular safety and risk minimisation advice
HPRA MIMS Resp Supp October 2018 - Clarithromycin
« Back
Date Printed: 19/04/2024